Professor Neil Watkins

Professor Watkins grew up in Perth before graduating from the University of WA, School Of Medicine. He then trained as a specialist physician at Sir Charles Gairdner and Royal Perth Hospitals before starting his research career with a PhD in Dr Phil Thompson's laboratory at the UWA Department of Medicine.  Read more >

Professor Paul Hertzog

Professor Paul Hertzog is the Director of the Centre for Innate Immunity and Infectious Diseases and a Principal Research Fellow of the National Health and Medical Research Council of Australia. Among his scientific achievements are publications in the highest ranking journals including Cell, Proceedings of the National Academy of Sciences, Blood, Journal of Biological Chemistry and Journal of Immunology, plus contributing to many book chapters and invited reviews.  Read more >

Professor Justin St. John

Before coming to MIMR, Prof Justin St. John was Professor of Reproductive Biology at Warwick Medical School, University of Warwick (UK). His research focusses on how the maternally inherited mitochondrial genome is replicated and transmitted as it passes from the egg through to the offspring. He is developing strategies to prevent the transmission of mutant mitochondrial DNA from one generation to the next. He has numerous publications in international journals including The Lancet, Nature Chemical Biology, Nature Cell Biology, Stem Cells, Journal of Cell Science, and Genetics. Prof St. John also reviews submissions for a number of journals and grant awarding bodies. Read more >

Professor Euan Wallace

Professor Euan Wallace is the Director of The Ritchie Centre. Previously, he was Clinical Director of MIMR’s Centre for Women’s Health Research.

Professor Wallace’s research group focuses on basic and clinical aspects of pregnancy. The team has an international reputation for its Down Syndrome screening research and for the investigation of inhibins and activins in pregnancy. More recently, the group has established research programs in neuroprotection in fetal growth restriction and in utero infection, and in novel therapies for preeclampsia. The group is a world leader in amnion stem cell biology and its potential for clinical applications. Read more >